Comment: The Effects of 14 Versus 21 Days of Nimodipine Therapy on Neurological Outcomes in Aneurysmal Subarachnoid Hemorrhage Patients

Abstract

Get full access to this article

View all access options for this article.

References

Cho

Bales

Tran

Korab

Khandelwal

Joffe

AM.

The effects of 14 versus 21 days of nimodipine therapy on neurological outcomes in aneurysmal subarachnoid hemorrhage patients. Ann Pharmacother. 2016;50:718-724.

Thornby

K-A

Johnson

Ferrill

MJ.

Simplifying and interpreting the FACTS of noninferiority trials: a stepwise approach. Am J Health Syst Pharm. 2014;71:1926-1931.

Dorhout Mees

Rinkel

GJE

Feigin

. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev. 2007;(3):CD000277. doi:10.1002/14651858.CD000277.pub3

Pickard

Murray

Illingworth

. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636-642.